Sialic acid (SA)-modified selenium nanoparticles coated with a high blood–brain barrier permeability peptide-B6 peptide for potential use in Alzheimer’s diseaseTiantian Yin, Jie Liu, Xianbo Zhou et al.|Acta Biomaterialia|2015Cited by 193
Gold nanoparticle-capped mesoporous silica-based H2O2-responsive controlled release system for Alzheimer’s disease treatmentLicong Yang, Jie Liu, Yanan Liu et al.|Acta Biomaterialia|2016Cited by 116
Peptide‐Modified Mo Polyoxometalate Nanoparticles Suppress Zn<sup>2+</sup>‐Induced Aβ AggregationYanan Liu, Jie Liu, Jing Sun et al.|ChemNanoMat|2019Cited by 13
Functionalized chitosan-modified defect-related luminescent mesoporous silica nanoparticles as new inhibitors for hIAPP aggregationXufeng Zhu, Lanmei Chen, Jie Liu et al.|Nanotechnology|2019Cited by 8